SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-117877
Filing Date
2011-04-29
Accepted
2011-04-29 12:57:48
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 479178
2 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE dex11.htm EX-11 14103
3 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES dex12.htm EX-12 20004
4 RULE 13A-14(A) CERTIFICATION dex311.htm EX-31.1 9451
5 RULE 13A-14(A) CERTIFICATION dex312.htm EX-31.2 9623
6 SECTION 1350 CERTIFICATION dex32.htm EX-32 4020
  Complete submission text file 0001193125-11-117877.txt   6550882

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lly-20110331.xml EX-101.INS 956178
8 XBRL TAXONOMY EXTENSION SCHEMA lly-20110331.xsd EX-101.SCH 33775
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lly-20110331_cal.xml EX-101.CAL 51726
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20110331_def.xml EX-101.DEF 90073
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20110331_lab.xml EX-101.LAB 265716
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20110331_pre.xml EX-101.PRE 197162
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 11792734
SIC: 2834 Pharmaceutical Preparations